In vitro and ex vivo functional characterization of human HLA-DRB1∗04 restricted T cell receptors

Todd, 1988, A molecular basis for MHC class II--associated autoimmunity, Science, 240, 1003, 10.1126/science.3368786 Nepom, 1991, MHC class-II molecules and autoimmunity, Annu. Rev. Immunol., 9, 493, 10.1146/annurev.iy.09.040191.002425 Terao, 2019, Distinct HLA associations with rheumatoid arthritis subsets defined by serological subphenotype, Am. J. Hum. Genet., 105, 616, 10.1016/j.ajhg.2019.08.002 Klareskog, 1982, Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis, Proc. Natl. Acad. Sci. U. S. A., 79, 3632, 10.1073/pnas.79.11.3632 Raychaudhuri, 2012, Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis, Nat. Genet., 44, 291, 10.1038/ng.1076 Anderson, 2016, A molecular analysis of the shared epitope hypothesis: binding of arthritogenic peptides to DRB1∗04 alleles, Arthritis Rheum., 68, 1627, 10.1002/art.39636 Klareskog, 1981, Relationship between HLA-DR-expressing cells and T lymphocytes of different subsets in rheumatoid synovial tissue, Scand. J. Immunol., 15, 501, 10.1111/j.1365-3083.1982.tb00676.x Galindo-Feria, 2020, Proinflammatory histidyl-transfer RNA synthetase-specific CD4+ T cells in the blood and lungs of patients with idiopathic inflammatory myopathies, Arthritis Rheum., 72, 179, 10.1002/art.41075 Pieper, 2018, Memory T cells specific to citrullinated alpha-enolase are enriched in the rheumatic joint, J. Autoimmun., 92, 47, 10.1016/j.jaut.2018.04.004 Gerstner, 2020, Multi-HLA class II tetramer analyses of citrulline-reactive T cells and early treatment response in rheumatoid arthritis, BMC Immunol., 21, 27, 10.1186/s12865-020-00357-w Wang, 2020 Delong, 2016, Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion, Science, 351, 711, 10.1126/science.aad2791 Pieper, 2018, Memory T cells specific to citrullinated α-enolase are enriched in the rheumatic joint, J. Autoimmun., 92, 47, 10.1016/j.jaut.2018.04.004 Shimoda, 2008, CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis, J. Autoimmun., 31, 110, 10.1016/j.jaut.2008.05.003 Kremer, 2003, Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig, N. Engl. J. Med., 349, 1907, 10.1056/NEJMoa035075 Orban, 2011, Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial, Lancet, 378, 412, 10.1016/S0140-6736(11)60886-6 Sumitomo, 2018, A gene module associated with dysregulated TCR signaling pathways in CD4(+) T cell subsets in rheumatoid arthritis, J. Autoimmun., 89, 21, 10.1016/j.jaut.2017.11.001 Ji, 1999, Different modes of pathogenesis in T-cell-dependent autoimmunity: clues from two TCR transgenic systems, Immunol. Rev., 169, 139, 10.1111/j.1600-065X.1999.tb01312.x Anderson, 2012, A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells, J. Immunol., 188, 2084, 10.4049/jimmunol.1102186 Berlo, 2005, Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation, J. Autoimmun., 25, 172, 10.1016/j.jaut.2005.09.017 Smolen, 2020, EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update, Ann. Rheum. Dis., 79, 685, 10.1136/annrheumdis-2019-216655 Benichou, 2012, Rep-Seq: uncovering the immunological repertoire through next-generation sequencing, Immunology, 135, 183, 10.1111/j.1365-2567.2011.03527.x De Simone, 2018, Single cell T cell receptor sequencing: techniques and future challenges, Front. Immunol., 9, 1638, 10.3389/fimmu.2018.01638 Bagaev, 2020, VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium, Nucleic Acids Res., 48, D1057, 10.1093/nar/gkz874 Corrie, 2018, iReceptor: a platform for querying and analyzing antibody/B-cell and T-cell receptor repertoire data across federated repositories, Immunol. Rev., 284, 24, 10.1111/imr.12666 Letourneur, 1989, Derivation of a T cell hybridoma variant deprived of functional T cell receptor alpha and beta chain transcripts reveals a nonfunctional alpha-mRNA of BW5147 origin, Eur. J. Immunol., 19, 2269, 10.1002/eji.1830191214 Ito, 1996, HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis, J. Exp. Med., 183, 2635, 10.1084/jem.183.6.2635 Danner, 2011, Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells, PloS One, 6, 10.1371/journal.pone.0019826 Sprouse, 2016, Rapid identification and expression of human TCRs in retrogenic mice, J. Immunol. Methods, 439, 29, 10.1016/j.jim.2016.08.010 Hewitt, 1992, Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor, J. Exp. Med., 175, 1493, 10.1084/jem.175.6.1493 Holst, 2008, Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity, Nat. Immunol., 9, 658, 10.1038/ni.1611 Landau, 1988, The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4, Nature, 334, 159, 10.1038/334159a0 Gerstner, 2020, Multi-HLA class II tetramer analyses of citrulline-reactive T cells and early treatment response in rheumatoid arthritis, BMC Immunol., 21, 1, 10.1186/s12865-020-00357-w Novak, 1999, MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen, J. Clin. Invest., 104, R63, 10.1172/JCI8476 Jutz, 2016, Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: simultaneous measurement of NF-kappaB, NFAT and AP-1, J. Immunol. Methods, 430, 10, 10.1016/j.jim.2016.01.007 Law, 1994, Human CD4 restores normal T cell development and function in mice deficient in murine CD4, J. Exp. Med., 179, 1233, 10.1084/jem.179.4.1233 Timmerman, 1996, Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression, Nature, 383, 837, 10.1038/383837a0 Imboden, 1985, Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores, J. Exp. Med., 161, 446, 10.1084/jem.161.3.446 Chow, 1999, Requirement for transcription factor NFAT in interleukin-2 expression, Mol. Cell Biol., 19, 2300, 10.1128/MCB.19.3.2300 Schwartz, 2017, JAK inhibition as a therapeutic strategy for immune and inflammatory diseases, Nat. Rev. Drug Discov., 16, 843, 10.1038/nrd.2017.201 Miller, 2007, Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease, Nat. Rev. Immunol., 7, 665, 10.1038/nri2153 Sabatos-Peyton, 2010, Antigen-specific immunotherapy of autoimmune and allergic diseases, Curr. Opin. Immunol., 22, 609, 10.1016/j.coi.2010.08.006 Green, 1994, Activation-induced apoptosis in lymphocytes, Curr. Opin. Immunol., 6, 476, 10.1016/0952-7915(94)90130-9 Varadhachary, 1997, Differential ability of T cell subsets to undergo activation-induced cell death, Proc. Natl. Acad. Sci. U. S. A., 94, 5778, 10.1073/pnas.94.11.5778 Srivastava, 2020, Tolerogenic nanoparticles impacting B and T lymphocyte responses delay autoimmune arthritis in K/BxN mice, bioRxiv Perera, 2013, Insufficient autoantigen presentation and failure of tolerance in a mouse model of rheumatoid arthritis, Arthritis Rheum., 65, 2847, 10.1002/art.38085 Tian, 1996, Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice, Nat. Med., 2, 1348, 10.1038/nm1296-1348 Krienke, 2021, A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis, Science, 371, 145, 10.1126/science.aay3638 Matzinger, 2011, Tissue-based class control: the other side of tolerance, Nat. Rev. Immunol., 11, 221, 10.1038/nri2940 Akamatsu, 2019, Conversion of antigen-specific effector/memory T cells into Foxp3-expressing Treg cells by inhibition of CDK8/19, Sci Immunol, 4, 10.1126/sciimmunol.aaw2707 Shade, 2020, Sialylation of immunoglobulin E is a determinant of allergic pathogenicity, Nature, 582, 265, 10.1038/s41586-020-2311-z Durham, 1999, Long-term clinical efficacy of grass-pollen immunotherapy, N. Engl. J. Med., 341, 468, 10.1056/NEJM199908123410702 Anagnostou, 2014, Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial, Lancet, 383, 1297, 10.1016/S0140-6736(13)62301-6 Noon, 1911, Lancet, 177, 1572, 10.1016/S0140-6736(00)78276-6 Holst, 2006, Generation of T-cell receptor retrogenic mice, Nat. Protoc., 1, 406, 10.1038/nprot.2006.61 Burton, 2008, On the pathogenicity of autoantigen-specific T-cell receptors, Diabetes, 57, 1321, 10.2337/db07-1129 Bettini, 2012, T-cell receptor retrogenic mice: a rapid, flexible alternative to T-cell receptor transgenic mice, Immunology, 136, 265, 10.1111/j.1365-2567.2012.03574.x Schinnerling, 2019, Humanized mouse models of rheumatoid arthritis for studies on immunopathogenesis and preclinical testing of cell-based therapies, Front. Immunol., 10, 203, 10.3389/fimmu.2019.00203 Pacheco, 2019, Bystander activation and autoimmunity, J. Autoimmun., 103, 102301, 10.1016/j.jaut.2019.06.012